| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 56495 |
| 1 | RITUXIMAB | 41722 |
| 2 | METHOTREXATE SODIUM | 40573 |
| 3 | INFLIXIMAB | 39684 |
| 4 | DENOSUMAB | 36810 |
| 5 | ACETAMINOPHEN | 35598 |
| 6 | METHOTREXATE | 35480 |
| 7 | ERGOCALCIFEROL | 23721 |
| 8 | PAIN RELIEVER | 23638 |
| 9 | ACETAMINOPHEN 500MG | 23632 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 15556 | 4.5142 |
| 1 | GOLIMUMAB | 10538 | 0.8368 |
| 2 | ERGOCALCIFEROL | 23721 | 0.7978 |
| 3 | PSYLLIUM HUSK | 841 | 0.6225 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 4820 | 0.5767 |
| 5 | RITUXIMAB-ABBS | 2347 | 0.4597 |
| 6 | HYDROCORTISONE SODIUM SUCCINATE | 1694 | 0.4243 |
| 7 | ALMOTRIPTAN | 414 | 0.3913 |
| 8 | BOTULINUM TOXIN TYPE A | 4939 | 0.3862 |
| 9 | AZATHIOPRINE SODIUM | 947 | 0.3734 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 119223 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 63010 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 58981 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 46220 |
| 4 | RANK Ligand Inhibitor [EPC] | 36808 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 36458 |
| 6 | Kinase Inhibitor [EPC] | 34343 |
| 7 | Benzodiazepine [EPC] | 31898 |
| 8 | Vitamin C [EPC] | 26432 |
| 9 | Atypical Antipsychotic [EPC] | 25338 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Autologous Cultured Cell [EPC] | 244 | 0.5410 |
| 1 | Interferon gamma Blocker [EPC] | 94 | 0.3966 |
| 2 | Adrenal Steroid Synthesis Inhibitor [EPC] | 383 | 0.3834 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 5297 | 0.3134 |
| 4 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 656 | 0.3012 |
| 5 | Bispecific HER2-directed Antibody [EPC] | 23 | 0.2805 |
| 6 | Melanocortin 4 Receptor Agonist [EPC] | 79 | 0.2772 |
| 7 | Lead Chelator [EPC] | 23 | 0.2738 |
| 8 | Integrin Receptor Antagonist [EPC] | 22428 | 0.2576 |
| 9 | Antidiarrheal [EPC] | 61 | 0.2552 |